721 related articles for article (PubMed ID: 19864379)
21. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
[TBL] [Abstract][Full Text] [Related]
22. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.
Wang H; Yang P; Liu K; Guo F; Zhang Y; Zhang G; Jiang C
Cell Res; 2008 Feb; 18(2):290-301. PubMed ID: 18227861
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
[TBL] [Abstract][Full Text] [Related]
24. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.
Huang IC; Bosch BJ; Li W; Farzan M; Rottier PM; Choe H
Adv Exp Med Biol; 2006; 581():335-8. PubMed ID: 17037556
[No Abstract] [Full Text] [Related]
26. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
27. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
Haga S; Nagata N; Okamura T; Yamamoto N; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y
Antiviral Res; 2010 Mar; 85(3):551-5. PubMed ID: 19995578
[TBL] [Abstract][Full Text] [Related]
28. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
[TBL] [Abstract][Full Text] [Related]
29. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
Li F
J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
[TBL] [Abstract][Full Text] [Related]
30. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.
Nagata N; Iwata N; Hasegawa H; Fukushi S; Yokoyama M; Harashima A; Sato Y; Saijo M; Morikawa S; Sata T
J Virol; 2007 Feb; 81(4):1848-57. PubMed ID: 17151094
[TBL] [Abstract][Full Text] [Related]
31. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
[TBL] [Abstract][Full Text] [Related]
32. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.
Li W; Zhang C; Sui J; Kuhn JH; Moore MJ; Luo S; Wong SK; Huang IC; Xu K; Vasilieva N; Murakami A; He Y; Marasco WA; Guan Y; Choe H; Farzan M
EMBO J; 2005 Apr; 24(8):1634-43. PubMed ID: 15791205
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.
Hou Y; Peng C; Yu M; Li Y; Han Z; Li F; Wang LF; Shi Z
Arch Virol; 2010 Oct; 155(10):1563-9. PubMed ID: 20567988
[TBL] [Abstract][Full Text] [Related]
35. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
36. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Kuba K; Imai Y; Rao S; Gao H; Guo F; Guan B; Huan Y; Yang P; Zhang Y; Deng W; Bao L; Zhang B; Liu G; Wang Z; Chappell M; Liu Y; Zheng D; Leibbrandt A; Wada T; Slutsky AS; Liu D; Qin C; Jiang C; Penninger JM
Nat Med; 2005 Aug; 11(8):875-9. PubMed ID: 16007097
[TBL] [Abstract][Full Text] [Related]
37. Insights from the association of SARS-CoV S-protein with its receptor, ACE2.
Li W; Choe H; Farzan M
Adv Exp Med Biol; 2006; 581():209-18. PubMed ID: 17037532
[No Abstract] [Full Text] [Related]
38. Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2.
Lan J; Chen P; Liu W; Ren W; Zhang L; Ding Q; Zhang Q; Wang X; Ge J
Structure; 2022 Oct; 30(10):1432-1442.e4. PubMed ID: 35917815
[TBL] [Abstract][Full Text] [Related]
39. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.
Jia HP; Look DC; Shi L; Hickey M; Pewe L; Netland J; Farzan M; Wohlford-Lenane C; Perlman S; McCray PB
J Virol; 2005 Dec; 79(23):14614-21. PubMed ID: 16282461
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
Chen IY; Chang SC; Wu HY; Yu TC; Wei WC; Lin S; Chien CL; Chang MF
J Virol; 2010 Aug; 84(15):7703-12. PubMed ID: 20484496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
